Vizgen
PrivateLast Round
Series E
Jan 8, 2026
Total Funding Raised
$291.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vizgen operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series E round in January 2026.
Vizgen is a biotechnology company that provides spatially resolved, single-cell gene expression profiling tools to enhance understanding of biological systems and diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vizgen Comparables
Compare Vizgen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Resolve Biosciences | 84% | |
| Stellaromics | 83% | |
| 10x Genomics | 81% |
For institutional investors. Book with your work email.
Vizgen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jan 8, 2026 | ||||
| Series D | Oct 9, 2024 | ||||
| Growth Equity | Mar 8, 2024 | ||||
| Series C | Jun 3, 2022 | ||||
| Series B | Apr 7, 2021 | ||||
Series A | Jan 30, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vizgen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| M Ventures | Series D, Series E |
| Northpond Ventures | Series C, Series D, Series B, Series A, Series E |
| ARCH Venture Partners | Series B, Series D, Series C, Series A, Series E |
| Blue Water Life Science Advisors | Series C |
| Novalis LifeSciences | Series C, Series B |
| Northpond Ventures | Series C, Series D, Growth Equity, Series B, Series A |
| Sofina | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
$48M Series E round completed.
- Nov 17, 2025
Collaboration with Ultivue to serve big pharma customers and CROs.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 10, 2026
Vizgen launches Velocity Lab, a centralized research foundry designed to generate decision-grade three-dimensional spatial biology data at industrial scale, in Massachusetts on Nov 10th '26.
For institutional investors. Book with your work email.
Vizgen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vizgen's valuation, stock price, and market status.
Is Vizgen a public or private company?
Vizgen is a private company.
What is the current stock price of Vizgen?
Vizgen is a private company, so its shares have no public market price. Caplight tracks Vizgen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vizgen worth (valuation)?
Valuation information for Vizgen is not publicly available.
Can I buy Vizgen stock?
Vizgen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vizgen's last funding round?
Vizgen's most recent funding round was Series E on January 8, 2026.
Who are the main investors in Vizgen?
Key investors in Vizgen include M Ventures, Northpond Ventures, ARCH Venture Partners, Blue Water Life Science Advisors, Novalis LifeSciences.
Will Vizgen IPO soon?
No public IPO plans have been announced for Vizgen.
How can I track Vizgen secondary market activity?
Caplight tracks bids, offers, and trades in Vizgen's shares on secondary markets.